Physician profile
Teresa E Thomas
NPI 1417976531
$1,808.05
in general payments reported to CMS, 2019-2025
20 companies · $14.20 in 2025
The $14.20 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,266 · 2020: $360 · 2021: $28.27 · 2023: $139 · 2025: $14.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $454.81 | 2019-2020 | |
| Abbvie INC. | $209.68 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $177.85 | 2019-2025 | Breztri |
| Glaxosmithkline, LLC. | $139.17 | 2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $134.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $117.43 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.07 | 2019 | |
| Amarin Pharma, INC. | $108.50 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $52.85 | 2019 | |
| Biodelivery Sciences International, INC. | $51.24 | 2019-2020 | |
| Mannkind Corporation | $47.96 | 2019 | |
| Abbott Laboratories | $41.85 | 2019 | |
| Amgen INC. | $26.99 | 2020 | |
| Xeris Pharmaceuticals, INC. | $25.66 | 2020-2021 | |
| Sanofi Pasteur INC. | $25.23 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $24.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.52 | 2019 | |
| Romark Laboratories, Lc | $14.79 | 2019 | |
| Redhill Biopharma INC. | $14.19 | 2020 | |
| Genentech USA, INC. | $14.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teresa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.